Clinical Trial Update: Evaluating Immunomodulatory Interventions in Post-Acute Sequelae of SARS-CoV-2 InfEction [NA]

View source ↗

Summary

A registered clinical trial is evaluating immunomodulatory interventions for post-acute sequelae of SARS-CoV-2 infection and is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Immunomodulatory Intervention (investigational)

Snippet

Sponsor: Huashan Hospital | Conditions: Post-acute Sequelae of SARS-COV-2 Infection | NA | Status: NOT_YET_RECRUITING